Insider Transactions in Q2 2023 at Immunity Bio, Inc. (IBRX)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 15
2023
|
Regan J Lauer Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
21,030
+50.0%
|
-
|
|
Jun 05
2023
|
Michael D Blaszyk Director |
BUY
Open market or private purchase
|
Indirect |
71,915
+30.29%
|
$143,830
$2.75 P/Share
|
|
Jun 02
2023
|
John Owen Brennan Director |
BUY
Open market or private purchase
|
Direct |
25,000
+39.52%
|
$50,000
$2.81 P/Share
|
|
Jun 01
2023
|
Wesley Clark Director |
BUY
Open market or private purchase
|
Direct |
7,000
+46.67%
|
$14,000
$2.91 P/Share
|